Ignite Creation Date:
2024-05-06 @ 7:11 PM
Last Modification Date:
2024-10-26 @ 3:02 PM
Study NCT ID:
NCT05921006
Status:
RECRUITING
Last Update Posted:
2023-07-06
First Post:
2023-06-15
Brief Title:
Ascending Single-Dose and Multiple-Dose Study to Evaluate RJ4287 in Healthy Subjects
Sponsor:
Nanjing Ruijie Pharma Co Ltd
Organization:
Nanjing Ruijie Pharma Co Ltd
Study Overview
Official Title:
A Phase 1 Double-blind Randomized Placebo-controlled First-in-human Study to Evaluate the Safety Tolerability Pharmacokinetics and Food-effect of Single and Multiple Oral Doses of RJ4287 in Healthy Volunteers
Status:
RECRUITING
Status Verified Date:
2023-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A Randomized Study of RJ4287 Drug to Evaluate the Safety Tolerability Pharmacokinetics and Food-effect of Single and Multiple Doses in Healthy Volunteers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None